Skip to main content

Glipizide

NDC 68071-4939 · NuCare Pharmaceuticals,Inc.

Generic nameGlipizide

Dosage formTABLET

RouteORAL

Active ingredient(s)GLIPIZIDE

Strength5 mg/1

Pharmacologic classSulfonylurea Compounds [CS], Sulfonylurea [EPC]

Marketing categoryANDA

Packages

68071-4939-1 — 100 TABLET in 1 BOTTLE (68071-4939-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

67046-0236 — Glipizide, 67046-0367 — Glipizide, 68071-3548 — Glipizide, 68071-3974 — Glipizide, 68071-4085 — Glipizide, 68071-4124 — Glipizide, 68071-4223 — Glipizide, 68071-4232 — Glipizide, 68071-4643 — Glipizide, 68071-4857 — Glipizide, 68382-184 — Glipizide and Metformin Hydrochloride, 68382-185 — Glipizide and Metformin Hydrochloride, 68382-186 — Glipizide and Metformin Hydrochloride, 68645-574 — Glipizide, 68645-575 — Glipizide, 68788-0141 — Glipizide, 68788-0142 — Glipizide, 68788-4017 — Glipizide, 68788-4020 — Glipizide, 68788-4061 — Glipizide, +132 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels